NCT07894471 Comparison of Surgery With Prehabilitation, Direct Surgery and Rehabilitation for Patients With Femoroacetabular Impingement
| NCT ID | NCT07894471 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Femoroacetabular Impingement Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 360 participants |
| Start Date | 2026-07-06 |
| Primary Completion | 2036-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 360 participants in total. It began in 2026-07-06 with a primary completion date of 2036-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to compare the therapeutic effects of three different treatment strategies for patients with femoroacetabular impingement. Participants will be randomly assigned to one of three groups: surgery combined with pre-rehabilitation, direct surgery without pre-rehabilitation, or rehabilitation alone. Researchers will follow-up participants and evaluate pain, joint function and other outcomes to find out which treatment works better.
Eligibility Criteria
Inclusion Criteria: 1. Presence of hip pain with imaging evidence of Cam- or Pincer-type femoroacetabular impingement morphology; 2. Age ≥ 16 years; 3. Able to provide written informed consent; 4. Physician judgment that the patient is likely to benefit from hip arthroscopic surgery or a rehabilitation program. Exclusion Criteria: 1. Concomitant hip osteoarthritis (Tönnis grade \> 1, or joint space \< 2 mm on the anteroposterior pelvic radiograph); 2. History of prior hip pathology, including Legg-Calvé-Perthes disease, slipped capital femoral epiphysis, or avascular necrosis of the femoral head; 3. History of prior hip trauma, including acetabular fracture, hip dislocation, or femoral neck fracture; 4. Previous hip surgery (open or arthroscopic); 5. Completion of a rehabilitation program specifically for FAIS within the past 12 months; 6. Hip dysplasia (lateral center-edge angle \< 20°).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07894471 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, studying Femoroacetabular Impingement Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07894471 currently recruiting?
Yes, NCT07894471 is actively recruiting participants. Contact the research team at yanxu@139.com for enrollment information.
Where is the NCT07894471 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT07894471 clinical trial?
NCT07894471 is sponsored by Peking University Third Hospital. The trial plans to enroll 360 participants.